Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Radiofrequency Ablation × Endocrine × Clear all

Phase

Status

Completed 3 Recruiting 2 Unknown 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 30 Head & Neck 4 Thoracic 3 Other solid neoplasm 2 Endocrine 1 Breast 1

Conditions

Hyperaldosteronism 1 Adrenocortical Adenoma 1

Interventions

lutetium Lu 177 dotatate 6 Everolimus 6 lanreotide 5 Temozolomide 5 anlotinib 4 Dexmedetomidine 4 surufatinib 3 Thyrotropin Alfa 3 Saline Solution 3 Injections 3 Cisplatin 3 Blood Specimen Collection 3 sintilimab 2 penpulimab 2 cabozantinib 2 Surgical Procedures, Operative 2 Sorafenib 2 Sodium Chloride 2 Rosiglitazone 2 Radiotherapy 2 Positron Emission Tomography Computed Tomography 2 Paclitaxel 2 Nivolumab 2 Metformin 2 Magnetic Resonance Spectroscopy 2 Lymph Node Excision 2 Liquid Biopsy 2 Fluorodeoxyglucose F18 2 Capecitabine 2 Biopsy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02030587 2017-04-25

LARFA

Chinese University of Hong Kong

Phase NA Unknown

Hyperaldosteronism, Adrenocortical Adenoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡